Transport of Paraquat by Human Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Family
- 1 August 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 322 (2) , 695-700
- https://doi.org/10.1124/jpet.107.123554
Abstract
Paraquat (N,N-dimethyl-4–4′-bipiridinium; PQ), a widely used herbicide, when ingested accidentally or intentionally can cause major organ toxicities in lung, liver, and kidney. Because PQ is primarily eliminated in the kidney, renal elimination, including tubular transport, plays a critical role in controlling systemic exposure to the herbicide. The goal of this study was to determine the molecular identities of the transporters involved in the renal elimination of PQ. Using stably transfected human embryonic kidney (HEK)-293 cells, we examined the role of human organic cation transporters (hOCTs, SLC22A1–3) and human multidrug and toxic compound extrusion (hMATE)1 in the cellular accumulation and cytotoxicity of PQ. We found that overexpression of hOCT2 but not hOCT1 and hOCT3 in HEK-293 cells significantly enhanced the accumulation and cytotoxicity of PQ (-fold increase for uptake was 12 ± 0.5, p < 0.01; -fold increase of cytotoxicity was 18 ± 1.5, p < 0.001). The kinetics of PQ transport was altered in cells expressing a genetic polymorphism of hOCT2 (A270S) in comparison with those expressing the reference hOCT2. In addition, the cellular accumulation and cytotoxicity of PQ were also enhanced in cells expressing hMATE1 (-fold increase for uptake was 18 ± 3.7, p < 0.0001; -fold increase of cytotoxicity was 5.7 ± 0.5, p < 0.0001). These results suggest that hOCT2 and hMATE1 mediate PQ transport. These transporters may play an important role in the accumulation and renal excretion of PQ, and they may serve as molecular targets for the prevention and treatment of PQ-induced nephrotoxicity.This publication has 27 references indexed in Scilit:
- Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family)The Journal of Pharmacology and Experimental Therapeutics, 2006
- Organic Cation Transporters Are Determinants of Oxaliplatin CytotoxicityCancer Research, 2006
- Identification and Functional Characterization of a New Human Kidney–Specific H+/Organic Cation Antiporter, Kidney-Specific Multidrug and Toxin Extrusion 2Journal of the American Society of Nephrology, 2006
- Lower Prevalence of the OCT2 Ser270 Allele in Patients with Essential HypertensionClinical and Experimental Hypertension, 2006
- Role of organic cation transporters in the renal handling of therapeutic agents and xenobioticsToxicology and Applied Pharmacology, 2005
- Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2Molecular Pharmacology, 2005
- Modeller: Generation and Refinement of Homology-Based Protein Structure ModelsPublished by Elsevier ,2003
- The Renal Excretory Mechanisms and the Role of Organic Cations in Modulating the Renal Handling of ParaquatPharmacology & Therapeutics, 1998
- The mechanism of excretion of paraquat in ratsToxicology Letters, 1997
- Paraquat2+/H+ exchange in isolated renal brush-border membrane vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995